CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

90. Monk, T.G., Goodnough, L.T., Brecher, M.E., Pulley, D.D., Colberg, J.W., Andriole, G.L., and
Catalona, W.J.: Acute Normovolemic Hemodilution Can Replace Preoperative Autologous Blood
Donation as a Standard of Care for Autologous Blood Procurement in Radical Prostatectomy. Anesth
Analg, 85:953-958, 1997.
91. Keetch, D.W., Andriole, G.L., Ratliff, T.L., and Catalona, W.J.: Comparison of Percentage-Free Prostate
Specific Antigen Levels in Men with Benign Prostatic Hyperplasia Treated with Finasteride, Terazosin,
or Watchful Waiting. Urology 50:901-905, 1997.
92. McConnell JD, Bruskewitz R, Walsh PC, Andriole, GL, et al: The effect of finasteride on the risk of
acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.
New Engl J Med 338(9):557-563, 1998.
93. Andriole, G.L., Guess, H.A., Epstein, J.I., Wise H., Kadmon, D., Crawford, E.D., Hudson, P., Jackson,
C.L., Romas, N.A., Patterson, L., Cook, T.J., Waldstreicher, J., and the PLESS Study Group: Treatment
with Finasteride Preserves Usefulness of Prostate-Specific Antigen in the Detection of Prostate Cancer:
Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Urology 52:195-202, 1998.
94. Ornstein, D.K., Oh, J., Herschman, JD and Andriole, G.L.: Evaluation and Management of the Man who
has Failed Primary Curative Therapy of Prostate Cancer. Urologic Clinics of North America 25(4):591-
601, 1998.
95. Ornstein, D.K., Smith, D.S., and Andriole, G.L.: Biochemical Response to Testicular Androgen
Ablation Among Advanced Prostate Cancer Patients Failing Flutamide and Finasteride Therapy.
Urology 52(6):1094-1097, 1998.
96. Ornstein D.K., Beiser, J.A., and Andriole, G.L.: Anaemia in Men Receiving Combined Finasteride and
Flutamide Therapy for Advanced Prostate Cancer. British Journal of Urology 83:43-46, 1998.
97. Roehrborn, CG, McConnell JD, Lieber M, et al: Serum Prostate-Specific Antigen Concentration is a
Powerful Predictor of Acute Urinary Retention and Need for Surgery in Men with Clinical Benign
Prostatic Hyperplasia. Urology 53:473-480, 1999.
98. Alexander F.E., Andriole, G.L., Aus G., et al: Rationale for Randomized Trials of Prostate Cancer
Screening. European Journal of Cancer, 35(2):262-271, 1999.
99. Andriole, G.L.: Editorial Comment: The Controversy About Androgen Deprivation Therapy for Prostate
Cancer. Infections in Urology 12(3):73, 1999.
100. Niemczyk, P., Klutke, C.G., and Andriole, G.L.: Technical Aspects of Umbilical
Appendicovesicostomy. Contemporary Urology: Surgeon’s Corner 11(8): 76-87, 1999.
101. Klutke, J.J., Chhikara, S., Andriole, G.L., and Klutke, C.G.: Long-Term Results After Antegrade
Collagen Injection for Stress Urinary Incontinence Following Radical Retropubic Prostatectomy.
Urology 53:974-977, 1999.
102. Hudson, P.B., Boake, R., Trachtenberg, J., Romas, N.A., Rosenblatt, S., Narayan P., Geller, J., Lieber,
M.M., Elhilali, M., Rittmaster, R., Cox, C.E., Perreault, J.P., Malek, G.H., Bruskewitz, R.C., Roy, J.B.,
Ko, A., Jacobsen C.A., Stoner, E., and the North American Finasteride Study Group: Efficacy of
Finasteride is Maintained in Patients with Benign Prostatic Hyperplasia Treated for 5 Years. Urology
53(4):690-695, 1999.
27